Fellows will receive a competitive stipend and benefit package, including comprehensive health insurance
2 openings available.
Employer will assist with relocation costs.
Novartis BioMedical Research , in collaboration with MCPHS, offers a unique fellowship program to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. A fellow gains extensive experiences through various practical activities in both industry and academic settings, which could enhance the potential for accelerated career development.
Clinical Operations - General Medicine Fellowship Overview:
The Clinical Sciences & Innovation (CS&I) department in Novartis Translational Medicine is a dynamic group of clinical scientists responsible for the conduct and evaluation of Phase I and Phase IIa clinical studies. These studies are designed to profile safety, tolerability, pharmacokinetics and pharmacodynamics, and to provide early proof of efficacy of novel compounds in humans. Globally, CS&I performs early clinical research in diabetes, cardiovascular and metabolic conditions, ophthalmology, musculoskeletal disorders, neuroscience, respiratory, autoimmunity, dermatology, transplantation and tropical diseases. Over 100 clinical sciences experts in multiple CS&I locations worldwide strive to support a smooth transition from discovery research to clinical practice-driven by a strong focus on clinical & data sciences, clinical innovation, patient centricity and strategic planning. Our fellows will train to become Clinical Scientists through assistance in delegated tasks to support the Clinical Trial Team in the conduct of clinical studies within Translational Medicine.
Our fellows will learn to: • Execute clinical trials in compliance with Novartis processes and current regulatory guidelines • Support study start-up activities through initial feasibility, development of operational plans and trial budgets • Develop and maintain essential trial documents such as Study Protocols, Informed Consent Forms, Pharmacy Manuals, Data Review Plans, and Clinical Trial Quality Risk Management Plans • Liaise with Novartis Country Organizations, Investigator sites, Clinical Research Associates (CRAs), Contract Research Organizations (CROs), vendors, and other suppliers to ensure study deliverables are met • Manage study and site performance via tracking of screening and enrollment activities, data entry, and protocol deviations • In collaboration with the Medical Expert and Clinical Trial Team, coordinate the ongoing medical review of the clinical trial data and coordinate the data analysis and interpretation for first interpretable results • Assist in the compilation of the clinical study report • Maintenance of knowledge and training of ICH-GCP, current regulations and procedures • Learn to work cross-culturally with colleagues and study sites around the world
To be considered for an interview, please complete a fellowship application on the MCPHS SMApply application portal. Visit https://mcphs.smapply.io/
Please DO NOT request an interview within PPS. Our recruitment teams will contact qualified candidates via email to schedule interviews.
The MCPHS application portal will open up on October 2, 2023. Applicants must upload the following application materials to the online portal by November 17, 2023:
Letter of intent
Unofficial college transcript
Contact information for three references. References will receive an electronic recommendation form to complete separately.
Incomplete applications WILL NOT be reviewed. Interviews CANNOT be scheduled until these materials have been submitted. Please keep in mind that this is a competitive process and applicants are encouraged to complete their applications as soon as possible.
Three recommendation evaluation forms must be submitted no later than November 27, 2023, via the online portal. This is NOT a letter of recommendation but an online form that the reference will need to complete.
Rolling Application Review & Interviews
All submitted applications will be reviewed on a rolling basis. Interviews will also be offered on a rolling basis and opportunities are limited. Priority will be given to those applicants who apply early, well in advance of the deadline.
Rolling interviews will begin mid-October with pre-screens and a mixture of interview rounds, and will conclude in December at the end of the ASHP Midyear Clinical Meeting. Candidates will be notified if selected for an interview.
ASHP Midyear & Onsite Interviews
The fellowship program will be conducting in-person interviews at the ASHP Midyear Clinical Meeting in Las Vegas. Applicants are strongly encouraged to attend. Candidates attending in-person will not be able to interview without registering for both ASHP and PPS. Please refer to the ASHP & PPS website for registration details.
Top candidates may be invited for interviews at the sponsoring company’s location pending COVID – 19 restrictions.
Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, MCPHS in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 13, 2023.
Final candidates will be required to go through additional screening / onboarding as required by MCPHS.
The MCPHS Biopharmaceutical Industry fellows will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy at the commencement of the program.
Candidates must have strong written and verbal communication skills and a strong interest in pursuing a career within the biopharmaceutical industry.
All candidates must have authorization to work in the United States throughout the duration of the one or two year fellowship. No visa sponsorship will be provided (i.e., TN, H-1B, STEM OPT, etc.).
The Novartis Biomedical Research unit is the innovation engine of Novartis. We collaborate across scientific and organizational boundaries, with a focus on powerful new technologies that have the potential to help produce therapeutic breakthroughs for patients.
The Novartis global clinical pipeline includes more than 200 projects and over 500 clinical trials. Within Novartis Biomedical Research, we have more than 5,600 dedicated scientists and physicians, working across 6 global campuses.